Centre urges states to stop unproven stem‑cell treatments for autism
Published · Updated
AI-generated summary of the coverage listed below: The Indian government has directed state authorities to curb the sale of unproven stem‑cell therapies marketed as routine care for autism. The directive aims to protect families from misleading claims and to enforce existing regulations, warning that clinics and doctors who continue to offer such treatments risk penalties. The move follows concerns that these therapies lack scientific validation and could exploit vulnerable patients.
Covered by 3 outlets across the spectrum: 0% left, 100% center, 0% right.
Who is covering this story
- Center (3): Indian Express, Hindustan Times, Mint
Sources
- Centre asks states to act on unproven stem cell therapies, warns doctors, clinics — Indian Express (center)
- Stem cell therapy only for approved conditions: Govt — Hindustan Times (center)
- Health ministry bars stem cell therapy for autism as routine care — Mint (center)